Hinge Health (HNGE) CFO reports 10,491-share sale in planned trade

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge reported selling 10,491 shares of Class A common stock on 12/22/2025 in an open-market transaction. The shares were sold at a weighted average price of $48.4069 per share, with individual sale prices ranging from $47.81 to $48.74. The transaction was executed under a Rule 10b5-1 trading plan that he adopted on June 12, 2025. Following this sale, Budge beneficially owns 441,174 shares of Hinge Health Class A common stock, held directly.

Insider Trade Summary

Net Seller: 10,491 shares ($507,837)

Net Sell 1 txn

Insider Budge James

Role Chief Financial Officer

Sold 10,491 shs ($508K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	10,491	$48.4069	$508K

Holdings After Transaction: Class A Common Stock — 441,174 shares (Direct)

Footnotes (1)

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. Represents the weighted average sale price. The lowest price at which shares were sold was $47.81 and the highest price at which shares were sold was $48.74. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/22/2025		S(1)		10,491	D	$48.4069(2)	441,174	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $47.81 and the highest price at which shares were sold was $48.74. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ James Budge	12/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hinge Health (HNGE) disclose in this filing?

The filing reports that Chief Financial Officer James Budge sold 10,491 shares of Hinge Health Class A common stock in an open-market transaction on 12/22/2025.

At what price did the Hinge Health (HNGE) CFO sell his shares?

The shares were sold at a weighted average price of $48.4069 per share. Individual sale prices ranged from $47.81 to $48.74 during the transaction.

How many Hinge Health (HNGE) shares does the CFO own after this sale?

After the reported sale, Chief Financial Officer James Budge beneficially owns 441,174 shares of Hinge Health Class A common stock, held directly.

Was the Hinge Health (HNGE) CFO sale made under a Rule 10b5-1 trading plan?

Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by James Budge on June 12, 2025.

What type of security did the Hinge Health (HNGE) CFO sell?

The transaction involved Class A common stock of Hinge Health, Inc., reported as a non-derivative security in Table I of the filing.

Does the filing provide more detail on the individual sale prices for HNGE shares?

Yes. It notes that $48.4069 is a weighted average price and explains that the CFO will provide full information on the number of shares sold at each separate price between $47.81 and $48.74 upon request.